thalidomide has been researched along with Keratitis in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Keratitis: Inflammation of the cornea.
Excerpt | Relevance | Reference |
---|---|---|
"Evaluate the effect of LASSBio-596, structurally designed as a new hybrid of thalidomide, on inflammatory corneal angiogenesis." | 7.78 | Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbits. ( Amaral de Moraes, ME; Barreiro, EJ; Lima, LM; Odorico de Moraes, M; Ribeiro, JC; Ribeiro, MZ; Ricardo, NM; Vagnaldo Fechine, F, 2012) |
"Evaluate the effect of LASSBio-596, structurally designed as a new hybrid of thalidomide, on inflammatory corneal angiogenesis." | 3.78 | Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbits. ( Amaral de Moraes, ME; Barreiro, EJ; Lima, LM; Odorico de Moraes, M; Ribeiro, JC; Ribeiro, MZ; Ricardo, NM; Vagnaldo Fechine, F, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ribeiro, JC | 1 |
Vagnaldo Fechine, F | 1 |
Ribeiro, MZ | 1 |
Barreiro, EJ | 1 |
Lima, LM | 1 |
Ricardo, NM | 1 |
Amaral de Moraes, ME | 1 |
Odorico de Moraes, M | 1 |
1 other study available for thalidomide and Keratitis
Article | Year |
---|---|
Potential inhibitory effect of LASSBio-596, a new thalidomide hybrid, on inflammatory corneal angiogenesis in rabbits.
Topics: Animals; Corneal Neovascularization; Dexamethasone; Disease Models, Animal; Glucocorticoids; Keratit | 2012 |